Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Role of FSH and FSH receptor on HUVECs migration



Follicle-stimulating hormone (FSH) is a pituitary glycoprotein that regulates follicle maturation through its binding to follicle-stimulating hormone receptor (FSHR). Endothelial cells express FSHR, but its exact role in endothelial cells remains unclear. Here we show that FSHR expression was detectable in human umbilical vein endothelial cells (HUVECs). FSH stimulation promoted HUVECs migration but not proliferation. Because FSHR is a GPCR, FSH treatment triggers the activation of cAMP-PKA signaling pathways, and the JAK-STAT, PI3K-AKT, and JNK-MAPK pathways. RNAi of FSHR dramatically attenuated the activation effect of FSH on HUVECs migration, as well as the related signaling pathways. Treatment of FSH in HUVECs also transcriptionally upregulated the expression of VAV3 and LAMA2, suppression either of VAV3 or LAMA2 by RNAi attenuated the FSH’s effect on HUVECs migration. All of these results indicated a functional role of FSH in the regulation of endothelial cells.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: FSHR expression in HUVECs.
Fig. 2: FSH regulates HUVEC migration.
Fig. 3: FSH triggers cAMP-PKA signaling.
Fig. 4: FSH activates signaling transduction.
Fig. 5: FSH regulates HUVECs migration through upregulating VAV3 and LAMA2.


  1. 1.

    Rice S, Elia A, Jawad Z, Pellatt L, Mason HD. Metformin inhibits follicle stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E1491–1500.

    CAS  Article  Google Scholar 

  2. 2.

    Sohn J, Ryu K, Sievert G, Jeoung M, Ji I, Ji TH. Follicle-stimulating hormone interacts with exoloop 3 of the receptor. J Biol Chem. 2002;277:50165–75.

    CAS  Article  Google Scholar 

  3. 3.

    Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997;18:739–73.

    CAS  PubMed  Google Scholar 

  4. 4.

    Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959–68.

    Article  Google Scholar 

  5. 5.

    Katari S, Wood-Trageser M, Jiang H, Kalynchuk H, Muzumdar R, Yatsenko SA, et al. Novel inactivating mutation of the FSH receptor in two siblings of indian origin with premature ovarian failure. J Clin Endocrinol Metab. 2015;100:2154–7.

    CAS  Article  Google Scholar 

  6. 6.

    Liu H, Xu X, Han T, Yan L, Cheng L, Qin Y, et al. A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency. Fertil Steril. 2017;108:1050–5.

    CAS  Article  Google Scholar 

  7. 7.

    Xie M, Li M, Zhou J, Ding X, Shao Y, Jing J, et al. Brain-derived neurotrophic factor promotes human granulosa-like tumor cell steroidogenesis and proliferation by activating the FSH receptor-mediated signaling pathway. Sci Rep. 2017;7:180.

    Article  Google Scholar 

  8. 8.

    Kong D, Guan Q, Li G, Xin W, Qi X, Guo Y, et al. Expression of FSHR in chondrocytes and the effect of FSH on chondrocytes. Biochem Biophys Res Commun. 2018;495:587–93.

    CAS  Article  Google Scholar 

  9. 9.

    Ponikwicka-Tyszko D, Chrusciel M, Stelmaszewska J, Bernaczyk P, Sztachelska M, Sidorkiewicz I, et al. Functional expression of FSH receptor in endometriotic lesions. J Clin Endocrinol Metab. 2016;101:2905–14.

    CAS  Article  Google Scholar 

  10. 10.

    Robin B, Planeix F, Sastre-Garau X, Pichon C, Olesen TK, Gogusev J, et al. Follicle-stimulating hormone receptor expression in endometriotic lesions and the associated vasculature. Reprod Sci. 2016;237:885–91.

    Article  Google Scholar 

  11. 11.

    Planeix F, Siraj MA, Bidard FC, Robin B, Pichon C, Sastre-Garau X, et al. Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery. J Exp Clin Cancer Res. 2015;34:12.

    Article  Google Scholar 

  12. 12.

    Pan B, Chen J, Lian J, Huang XF, Deng C. Unique effects of acute aripiprazole treatment on the dopamine D2 receptor downstream cAMP-PKA and Akt-GSK3ß signaling pathways in rats. PLoS One. 2015;10:e0132722.

    Article  Google Scholar 

  13. 13.

    Kenneth A. Jacobson. New paradigms in GPCR drug discovery. Biochem Pharmacol. 2015;98:541–55.

    Article  Google Scholar 

  14. 14.

    Stilley JA, Guan R, Duffy DM, Segaloff DL. Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis. J Clin Endocrinol Metab. 2014;99:E813–E820.

    CAS  Article  Google Scholar 

  15. 15.

    Siraj A, Desestret V, Antoine M, Fromont G, Huerre M, Sanson M, et al. Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer. 2013;13;246.

    CAS  Article  Google Scholar 

  16. 16.

    Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell. 2006;125:247–60.

    CAS  Article  Google Scholar 

  17. 17.

    Legg JA, Herbert JM, Clissold P, Bicknell R. Slits and roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis. 2008;11:13–21.

    Article  Google Scholar 

  18. 18.

    Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernández MM, et al. Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8. FASEB J. 2011;25:242–54.

    CAS  Article  Google Scholar 

  19. 19.

    Casarini L, Crépieux P, Reiter E, Lazzaretti C, Paradiso E, Rochira V, et al. FSH for the treatment of male infertility. Int J Mol Sci. 2020;21:2270.

    CAS  Article  Google Scholar 

  20. 20.

    Behre HM. Clinical Use of FSH in Male Infertility. Front. Endocrinol. 2019;10:322.

    Article  Google Scholar 

  21. 21.

    George AL, Rajoria S, Suriano R, Mittleman A, Tiwari RK. Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Mol Cancer. 2012;11:80.

    CAS  Article  Google Scholar 

Download references


This project was supported by Hubei Province Health and family planning scientific research project (WJ2016-YZ-16) and 81501373 from National Science Foundation of China.

Author information



Corresponding authors

Correspondence to Danjun Ma or Fangfang Tong.

Ethics declarations

Conflict of interest

Authors state no conflict of interest. We would like to thank LetPub ( for providing linguistic assistance during the preparation of this manuscript.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tan, D., Zhao, Y., Ma, D. et al. Role of FSH and FSH receptor on HUVECs migration. Gene Ther 28, 155–161 (2021).

Download citation

Further reading


Quick links